David Kerstein - Net Worth and Insider Trading

David Kerstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Kerstein owns 3 companies in total, including Anchiano Therapeutics Ltd (CMMB) , Chemomab Therapeutics Ltd (CMMB) , and Theseus Pharmaceuticals Inc (THRX) .

Click here to see the complete history of David Kerstein’s form 4 insider trades.

Insider Ownership Summary of David Kerstein

Ticker	Comapny	Transaction Date	Type of Owner
CMMB	Anchiano Therapeutics Ltd	2020-01-01	Chief Medical Officer
CMMB	Chemomab Therapeutics Ltd	2020-01-01	Chief Medical Officer
THRX	Theseus Pharmaceuticals Inc	2021-10-06	Chief Medical Officer

David Kerstein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Kerstein Ownership Network

Ownership Network List of David Kerstein

No Data

Ownership Network Relation of David Kerstein

David Kerstein Owned Company Details

What does Anchiano Therapeutics Ltd do?

Who are the key executives at Anchiano Therapeutics Ltd?

David Kerstein is the Chief Medical Officer of Anchiano Therapeutics Ltd. Other key executives at Anchiano Therapeutics Ltd include Chief Financial Officer Stephen J. Dipalma , other: Affiliate of 10% Owner Len Blavatnik , and 10 percent owner Access Industries Holdings Llc .

Anchiano Therapeutics Ltd (CMMB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anchiano Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anchiano Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anchiano Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anchiano Therapeutics Ltd Insider Transactions

No Available Data

What does Chemomab Therapeutics Ltd do?

Who are the key executives at Chemomab Therapeutics Ltd?

David Kerstein is the Chief Medical Officer of Chemomab Therapeutics Ltd. Other key executives at Chemomab Therapeutics Ltd include 10 percent owner Orbimed Israel Biofund Gp Limited Partnership , director & 10 percent owner & Chief Executive Officer George Adi Mor , and Chief Medical Officer Matthew Bejosa Frankel .

Chemomab Therapeutics Ltd (CMMB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chemomab Therapeutics Ltd Insider Transactions

No Available Data

What does Theseus Pharmaceuticals Inc do?

Who are the key executives at Theseus Pharmaceuticals Inc?

David Kerstein is the Chief Medical Officer of Theseus Pharmaceuticals Inc. Other key executives at Theseus Pharmaceuticals Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Orbimed Advisors Llc , and 10 percent owner Foresite Capital Fund V, L.p. .

Theseus Pharmaceuticals Inc (THRX) Insider Trades Summary

Over the past 18 months, David Kerstein made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 700,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 479,932 shares made by Orbimed Advisors Llc , and a net purchase of 479,932 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 1,659,864 shares were bought by its insiders, resulting in a net purchase of 1,659,864 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Theseus Pharmaceuticals Inc Insider Transactions

No Available Data

David Kerstein Mailing Address

Above is the net worth, insider trading, and ownership report for David Kerstein. You might contact David Kerstein via mailing address: 1/3 High-tech Village, Givat Ram, P.o. Box 39264, Jerusalem L3 9139102.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.